Revenue segments as reported by the company.

Premium and service revenues

Premium tax

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Depreciation

Amortization of acquired intangible assets

Premium tax expense

Health insurer fee expense

Impairment

Legal settlement

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Centene

Centene Corp. operates as a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Managed Care and Specialty Services. The Medicaid Managed Care segment provides health plan coverage to individuals through government subsidized programs through Medicaid. The Specialty Services segment offers healthcare services and products to state programs, correctional facilities, healthcare organizations, employer groups, and other commercial organizations. The company was founded in 1984 and is headquartered in St. Louis, MO.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Centene exceeds earnings guidance, eyes growth in Marketplace products

Centene's Q4 2022 earnings call highlighted robust financial performance, successful execution of value-creation plans, and a focus on operational efficiency. While challenges in Medicare Advantage margins are anticipated, opportunities in the Marketplace business and cost-cutting initiatives offer avenues for growth. Strategic initiatives to address demographic shifts and enhance care relationships position Centene for future success.

Centene reports strong Q1 earnings, focuses on growth opportunities

Centene's Q1 performance reflects strength in financial results and a strategic outlook for future growth.
Despite challenges in Medicare profitability and Medicaid redeterminations, Centene remains focused on maximizing membership and maintaining high margins.
Opportunities in enhancing relationships, investing in infrastructure, and updating margin assumptions position Centene for long-term success.

Centene reports strong Q2 earnings, raises 2023 outlook amidst challenges

Centene's Q2 earnings call showcased robust financial performance, operational efficiencies, and strategic wins in Medicaid and Marketplace segments. While facing challenges in cost trends and Star ratings strategy, the company is well-positioned for growth through revenue expansion and value-creation initiatives. Opportunities for engagement with key stakeholders and successful outreach efforts present avenues for continued success.

Centene exceeds Q3 earnings expectations, eyes growth opportunities in 2024

Centene's Q3 2023 earnings call highlighted strong financial performance, progress in Medicaid redeterminations, and operational advancements. The company anticipates continued growth in adjusted EPS for 2023 and 2024, with a focus on margin expansion and operational efficiencies. Challenges include managing membership declines and addressing questions on business plans and cost implications.

Centene exceeds 2023 expectations, poised for growth in 2024

Centene's 2023 performance was strong, exceeding expectations and positioning the company for continued growth. Key initiatives in Medicaid, Medicare Advantage, and Marketplace are driving revenue growth and operational efficiency. Challenges in managing utilization trends and achieving target margins require ongoing attention.

Centene surpasses Q1 earnings expectations, eyes growth in Medicaid and Marketplace

Centene's Q1 performance exceeded expectations, showcasing strength in Medicaid and Marketplace segments.
While facing challenges in contract protests and operational clarity, the company's strategic focus on Medicare Advantage and growth opportunities remain key strengths.
With a robust financial outlook and ongoing initiatives for optimization, Centene is well-positioned for continued success in the healthcare market.
Investors can be optimistic about Centene's growth trajectory, supported by strong operational performance and strategic initiatives.

Centene reports robust Q2 earnings, eyes Medicaid rebound and Medicare growth

Centene's Q2 2024 earnings call highlighted strong performance, Medicaid challenges, and growth opportunities in Medicaid and Medicare markets. Leadership transitions and focus on program innovation are key areas of development for the company.

Centene surpasses Q3 earnings expectations, eyes growth amid challenges

Centene's Q3 performance exceeded expectations, driven by improvements in Medicaid and strong Medicare and Marketplace segments.
Despite challenges in Medicaid and competitive pressures, Centene remains confident in its future growth and operational enhancements.
The company's strategic focus on AI, margin expansion, and quality improvement positions it well for continued success and profitability.
Analyst inquiries and company responses highlighted key areas of focus and potential areas for improvement and growth.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Centene Corp. is a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment includes the Temporary Assistance for Needy Families program, Medicaid Expansion programs, the Aged, Blind or Disabled program, the Children's Health Insurance Program, Long-Term Services and Supports, Foster Care, Medicare-Medicaid Plans, which cover beneficiaries who are dually eligible for Medicaid and Medicare, and other state-based programs. The Medicare segment consists of Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans, and Medicare Prescription Drug Plans. The Commercial segment is involved in the Health Insurance Marketplace product along with individual, small group, and large group commercial health insurance products. The Other segment refers to pharmacy operations, Envolve Benefit Options’ vision and dental services, clinical healthcare, behavioral health, international operations, and corporate management companies. The company was founded in 1984 and is headquartered in St. Louis, MO.

ST. LOUIS, July 29, 2021 /PRNewswire/ -- Centene Corporation (NYSE: CNC) ("Centene" or the "Company") announced today that it has priced its previously announced underwritten public offering of $1,800,000,000 aggregate principal amount of senior notes. The $1,800,000,000 offering of senior notes will include $500,000,000 aggregate principal amount of additional 2.450% senior notes due 2028 (the "Additional 2028 Notes") at a premium to yield 2.31% and $1,300,000,000 aggregate principal amount of new 2.625% senior notes due 2031 (together with the Additional 2028 Notes, the "Notes").

Centene Corporation Prices Offering of Senior Notes

SACRAMENTO, Calif.--(BUSINESS WIRE)--Health Net, one of California's longest-serving Medi-Cal partners, announced today it has named a new regional leadership team, which aims to close care gaps, improve health outcomes, and address health equity for the health plan's more than 2 million Medi-Cal members across the state. For decades, Health Net has worked hand-in-hand with California to build the state's Medi-Cal program. Today, more than two-thirds of Health Net's members are Medi-Cal enrolle

Health Net Names New Leadership Team to Help Improve Health Outcomes, Address Health Equity for Medi-Cal Members Across the State

ST. LOUIS, July 29, 2021 /PRNewswire/ -- Centene Corporation (NYSE: CNC) ("Centene" or the "Company") announced today that it has commenced an underwritten public offering to sell $1,800,000,000 of senior notes. The $1,800,000,000 offering of senior notes will include an add-on to its 2.450% senior notes due 2028 (the "2028 Notes") and new senior notes due 2031 (together with the 2028 Notes, the "Notes"), subject to market and other conditions.

Centene Corporation Announces Offering of Senior Notes

Centene's (CNC) second-quarter earnings gain from better revenues and membership growth.

Centene's (CNC) Q2 Earnings Miss Estimates, Improve Y/Y

Centene Corporation (CNC) CEO Michael Neidorff on Q2 2021 Results - Earnings Call Transcript

(Reuters) -Centene Corp on Tuesday became the latest U.S. health insurer to warn of higher COVID-19 costs in the coming quarters due to the impact of the Delta variant, which has become the dominant coronavirus strain globally.

Centene says COVID-19 costs could rise in coming quarters as Delta poses threat

Centene (CNC) delivered earnings and revenue surprises of -11.35% and 2.96%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Centene (CNC) Misses Q2 Earnings Estimates

Centene Corporation (NYSE: CNC) reported Q2 adjusted EPS of $1.25, missing the consensus estimate of $1.39 and lower than $2.40 reported a year ago. Sales for the quarter increased 12% Y/Y to $31.0 billion, slightly ahead of the consensus of $30.1 billion.

Centene Reports Mixed Bag On Q2 Earnings, Raises FY2021 Sales Outlook

Over the past few years, primarily through acquisition, Centene has become the market leader in the publicly-backed healthcare management space, driving significant revenue growth.

Where Can Centene Dominate Next?

Shares of Centene (NYSE:CNC) were unchanged after the company reported Q2 results. Quarterly Results Earnings per share decreased 47.92% over the past year to $1.25, which missed the estimate of $1.39.

Centene: Q2 Earnings Insights

Centene Corp. posted better-than-expected adjusted second-quarter profit Tuesday and offered guidance that was above consensus. The healthcare company had a loss of $535 million, or 92 ce3nts a share, in the quarter, after income of $1.206 billion, or $2.08 a share, in the year-earlier period.

Centene posts better-than-expected adjusted profit, offers upbeat guidance

ST. LOUIS, July 27, 2021 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today its financial results for the second quarter ended June 30, 2021, reporting diluted loss per share of $(0.92) and adjusted diluted earnings per share (EPS) of $1.25. In summary, the 2021 second quarter results were as follows: Total revenues (in millions) $ 31,025 Health benefits ratio 88.3 % SG&A expense ratio 7.9 % Adjusted SG&A expense ratio (1) 7.7 % GAAP diluted loss per share $ (0.92) Adjusted diluted EPS (1) $ 1.25 Total cash flow provided by operations (in millions) $ 1,685 (1) A full reconciliation of the adjusted SG&A expense ratio and adjusted diluted EPS is shown on page 6 of this release.

Centene Corporation Reports Second Quarter 2021 Results

Centene's (CNC) second-quarter results are likely to reflect escalated expenses, partly offset by improved revenues.

What's in the Cards for Centene's (CNC) Earnings in Q2?

SACRAMENTO, Calif.--(BUSINESS WIRE)--In response to Gov. Gavin Newsom's declared states of emergency in Siskiyou, Lassen and Plumas counties, Health Net is providing special assistance to members in these counties. The company is taking steps to ensure members affected by fires can access essential prescription medications and have important information about their benefits if their services are interrupted. Prescription Information During the duration of the state of emergency, members in coun

Health Net Assisting Members Across Siskiyou, Lassen and Plumas Counties during State of Emergency

ST. LOUIS, July 15, 2021 /PRNewswire/ -- Centene Corporation (NYSE: CNC) today announced that Colin Toney, Senior Vice President, Enterprise Strategy Group, has been appointed to Executive Vice President, Mergers and Acquisitions, effective immediately. Mr. Toney will report to Chairman, President, and CEO Michael Neidorff.

Centene Names Colin Toney Executive Vice President, Mergers And Acquisitions

ST. LOUIS, July 13, 2021 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today an organizational enhancement approved by the Board of Directors. In an effort to further recognize the size and scale of the company, broaden executives' capabilities, and support Centene's continued growth and innovation, the company has created the Office of the President (OOP).

Centene Announces Organizational Enhancements, Establishes The Office Of The President

SACRAMENTO, Calif.--(BUSINESS WIRE)--Health Net ranks the highest in customer service among Health Insurers in Forrester's proprietary 2021 US Customer Experience Index (CX Index™) survey. The ranking was based on responses from more than 85,000 US survey respondents from 13 US industries, including health care plans. “With decades of experience caring for California's most vulnerable residents, we've worked hand-in-hand with the state to serve those who depend on the healthcare safety net the

Health Net Ranks Highest In Customer Service Among Health Insurers

Within the last quarter, Centene (NYSE:CNC) has observed the following analyst ratings: Last 30 Days 1 Month Ago 2 Months Ago 3 Months Ago Bullish 1 2 1 0 Somewhat Bullish 0 2 3 0 Indifferent 0 1 0 0 Somewhat Bearish 0 0 0 0 Bearish 0 0 0 0 10 analysts offering 12-month price targets in the last 3 months for Centene evaluate the company at an average price target of $87.4 with a high of $93.00 and a low of $75.00.

What 10 Analyst Ratings Have To Say About Centene

TROY, Mich., June 28, 2021 /PRNewswire/ -- The Centers for Medicare & Medicaid Services (CMS) announced that in the Sixth Performance Year of the now extended Ten-year Independence at Home (IAH) Demonstration, U.S. Medical Management (USMM) and its affiliate Visiting Physicians Association (VPA) achieved improvements in quality of patient care, while reducing overall healthcare costs for homebound elderly patients with complex, chronic conditions.

U.S. Medical Management, and its Affiliate Visiting Physicians Association, Improves Health and Reduces Costs for the Frail Elderly under the CMS Independence at Home Demonstration - for Sixth Consecutive Year

Centene (CNC) exhibits prudence in issuing notes to procure funds for executing the transaction of its Magellan Health acquisition.

Centene (CNC) Offers Senior Notes Priced at $1.8 Billion

ST. LOUIS, June 25, 2021 /PRNewswire/ -- Centene Corporation (NYSE: CNC) today issued a reminder that it will release its 2021 second quarter financial results at approximately 6 a.m. (Eastern Time) on Tuesday, July 27, 2021, and host a conference call afterwards at approximately 8:30 a.m.

Reminder: Centene Corporation's 2021 Second Quarter Financial Results Conference Call

ST. LOUIS and CHARLOTTE, N.C., June 21, 2021 /PRNewswire/ -- Today, Centene Corporation (NYSE: CNC) dedicated its new East Coast headquarters in Charlotte.

Centene Dedicates New East Coast Headquarters In Charlotte

Community Health Systems

HCA Healthcare

Humana

Molina Healthcare

UnitedHealth Group

Insurers and hospital companies are now in conducive regulatory environment with the ACA getting a thumbs up from the Supreme Court.

Obamacare Upheld in Recent Rulings: A Boon for Healthcare

Analysts have provided the following ratings for Centene (NYSE:CNC) within the last quarter: Last 30 Days 1 Month Ago 2 Months Ago 3 Months Ago Bullish 2 1 0 0 Somewhat Bullish 2 1 2 0 Indifferent 1 0 0 0 Somewhat Bearish 0 0 0 0 Bearish 0 0 0 0 In the last 3 months, 10 analysts have offered 12-month price targets for Centene. The company has an average price target of $84.9 with a high of $93.00 and a low of $65.00.

Where Centene Stands With Analysts

ST. LOUIS, June 17, 2021 /PRNewswire/ -- Centene Corporation (NYSE: CNC) has announced the winners of the Centene Institute Youth Impact Award for Vaping Prevention. The national program is a curriculum and contest for adolescents ages 14 through 19 to raise awareness about vaping, e-cigarette use and prevention.

News for Centene Stock (CNC)